Are prescribed benzodiazepines likely to affect the availability of the 18 kda translocator protein (TSPO) in PET studies?

Synapse

Volumn 67, Issue 12, 2013, Pages 909-912

  Kalk, N J ^a   Owen, D R ^a   Tyacke, R J ^a   Reynolds, R ^a   Rabiner, E A ^b   Lingford hughes, A R ^a   Parker, C A ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CARBON 11; CARRIER PROTEIN; DIAZEPAM; LORAZEPAM; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NORDAZEPAM; OXAZEPAM; PBR 28 C 11; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; BLADDER CANCER; BRAIN TISSUE; CLINICAL RESEARCH; CONGESTIVE HEART FAILURE; FIBROSING ALVEOLITIS; HEART ATRIUM FIBRILLATION; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LOW TEMPERATURE; LUNG CANCER; MACROPHAGE ACTIVATION; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL;

AMIDES; BENZODIAZEPINES; BRAIN; HUMANS; ISOQUINOLINES; POSITRON-EMISSION TOMOGRAPHY; PYRIMIDINES; RADIOPHARMACEUTICALS; RECEPTORS, GABA;

EID: 84885866720     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21681     Document Type: Article

References (24)

1. Boxenbaum HG, Geitner KA, Jack ML, Dixon WR, Spiegel HE, Symington J, Christian R, Moore JD, Weissman L, Kaplan SA. 1977a. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routes. J Pharmacokinet Biopharm 5:3-23.
2. Boxenbaum HG, Geitner KA, Jack ML, Dixon WR, Spiegel HE, Symington J, Christian R, Moore JD, Weissman L, Kaplan SA. 1977b. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: Multiple-dose oral administration. J Pharmacokinet Biopharm 5:25-39.
3. Brooks DJ, Pavese N. 2011. Imaging biomarkers in Parkinson's disease. Prog Neurobiol 95:614-628.
4. Cagnin A, Kassiou M, Meikle SR, Banati RB. 2006. In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol Scand Suppl 185:107-114.
5. Camici PG, Rimoldi OE, Gaemperli O, Libby P. 2012. Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J 33:1309-1317.
6. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. Doble A, Malgouris C, Daniel M, Daniel N, Imbault F, Basbaum A, Uzan A, Gueremy C, Le Fur G. 1987. Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution. Brain Res Bull 18:49-61.
8. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC. 2009. Neuroinflammation in schizophrenia-related psychosis: A PET study. J Nucl Med 50:1801-1807.
9. Dundee JW, McGowan WA, Lilburn JK, McKay AC, Hegarty JE. 1979. Comparison of the actions of diazepam and lorazepam. Br J Anaesth 51:439-446.
10. Kanto J, Iisalo E, Lehtinen V, Salminen J. 1974. The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia 36:123-131.
11. Kanto J, Kangas L, Siirtola T. 1975. Cerebrospinal-fluid concentration of diazepam and its metabolites in man. Acta Pharmacol Toxicol 36:328-334.
12. Le Fur G, Vaucher N, Perrier ML, Flamier A, Benavides J, Renault C, Dubroeucq MC, Gueremy C, Uzan A. 1983. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 33:449-457.
13. Owen DR, Howell OW, Tang SP, Wells LA, Bennacef I, Bergstrom M, Gunn RN, Rabiner EA, Wilkins MR, Reynolds R, Matthews PM, Parker CA. 2010. Two binding sites for [3H]PBR28 in human brain: Implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab30:1608-1618.
14. Owen DR, Piccini P, Matthews PM. 2011. Towards molecular imaging of multiple sclerosis. Mult Scler 17:262-272.
15. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP. 2012. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 32:1-5.
16. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. 2006. Translocator protein (18kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402-409.
17. Rao VL, Butterworth RF. 1997. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. Eur J Pharmacol 340:89-99.
18. Rutherford DM, Okoko A, Tyrer PJ. 1978. Plasma concentrations of diazepam and desmethyldiazepam during chronic diazepam therapy. Br J Clin Pharmacol 6:69-73.
19. Scarf AM, Kassiou M. 2011. The translocator protein. J Nucl Med 52:677-680.
20. Schwagmeier R, Alincic S, Striebel HW. 1998. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol 46:203-206.
21. Tokuda K, O'Dell KA, Izumi Y, Zorumski CF. 2010. Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J Neurosci30:16788-16795.
22. Venneti S, Lopresti BJ, Wiley CA. 2006. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging. Prog Neurobiol 80:308-322.
23. Vinik HR, Reves JG, Greenblatt DJ, Abernethy DR, Smith LR. 1983. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 59:390-394.
24. Wyatt SK, Manning HC, Bai M, Bailey SN, Gallant P, Ma G, McIntosh L, Bornhop DJ. 2010. Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer. Mol Imaging Biol 12(3):349-358.